Trials / Sponsors / Invion, Inc.
Invion, Inc.
Industry · 4 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Efficacy and Safety of Βeta-adrenoceptor Inverse Agonist and Biased Ligand, Nadolol, In Smoking Cessation of P Smoking Cessation | Phase 2 | 2014-03-01 |
| Completed | Double-Blinded, Randomized, Placebo-Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics Lupus Erythematosus, Systemic | Phase 1 / Phase 2 | 2013-07-01 |
| Unknown | Efficacy and Safety of Beta-adrenoceptor Inverse Agonist, Nadolol, in Mild Asthma Mild Persistent Asthma, Uncomplicated | Phase 2 | 2013-03-01 |
| Completed | Oral Nadolol for the Treatment of Adults With Mild Asthma Asthma | Phase 1 / Phase 2 | 2007-01-01 |